#BEGIN_DRUGCARD DB03984

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C24H29N3O4S

# Chemical_IUPAC_Name:
(2S)-N-[(2R)-1-(benzylsulfanyl)-3-oxopropan-2-yl]-2-{[(morpholin-4-yl)carbonyl]amino}-3-phenylpropanamide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide

# HET_ID:
C4P

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C24H29N3O4S/c28-16-21(18-32-17-20-9-5-2-6-10-20)25-23(29)22(15-19-7-3-1-4-8-19)26-24(30)27-11-13-31-14-12-27/h1-10,16,21-22H,11-15,17-18H2,(H,25,29)(H,26,30)/t21-,22+/m1/s1

# InChI_Key:
InChIKey=MWTQNXVXPLTHJB-YADHBBJMSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3984

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
455.57

# Molecular_Weight_Mono:
455.187877121

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1NQC

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.94

# Predicted_LogS:
-5

# Predicted_Water_Solubility:
4.94e-03 g/l

# Primary_Accession_No:
DB03984

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5287870

# PubChem_Substance_ID:
46507654

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00813

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@](CSCC1=CC=CC=C1)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)N1CCOCC1)C=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:49 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Lysosome

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
CTSS

# Drug_Target_1_GenBank_ID_Gene:
S93414

# Drug_Target_1_GenBank_ID_Protein:
248406

# Drug_Target_1_GeneCard_ID:
CTSS

# Drug_Target_1_Gene_Name:
CTSS

# Drug_Target_1_Gene_Sequence:
>996 bp
ATGAAACGGCTGGTTTGTGTGCTCTTGGTGTGCTCCTCTGCAGTGGCACAGTTGCATAAA
GATCCTACCCTGGATCACCACTGGCATCTCTGGAAGAAAACCTATGGCAAACAATACAAG
GAAAAGAATGAAGAAGCAGTACGACGTCTCATCTGGGAAAAGAATCTAAAGTTTGTGATG
CTTCACAACCTGGAGCATTCAATGGGAATGCACTCATACGATCTGGGCATGAACCACCTG
GGAGACATGACCAGTGAAGAAGTGATGTCTTTGACGAGTTCCCTGAGAGTTCCCAGCCAG
TGGCAGAGAAATATCACATATAAGTCAAACCCTAATCGGATATTGCCTGATTCTGTGGAC
TGGAGAGAGAAAGGGTGTGTTACTGAAGTGAAATATCAAGGTTCTTGTGGTGCTTGCTGG
GCTTTCAGTGCTGTGGGGGCCCTGGAAGCACAGCTGAAGCTGAAAACAGGAAAGCTGGTG
ACTCTCAGTGCCCAGAACCTGGTGGATTGCTCAACTGAAAAATATGGAAACAAAGGCTGC
AATGGTGGCTTCATGACAACGGCTTTCCAGTACATCATTGATAACAAGGGCATCGACTCA
GACGCTTCCTATCCCTACAAAGCCATGGATCAGAAATGTCAATATGACTCAAAATATCGT
GCTGCCACATGTTCAAAGTACACTGAACTTCCTTATGGGAGAGAAGATGTCCTGAAAGAA
GCTGTGGCCAATAAAGGCCCAGTGTCTGTTGGTGTAGATGCGCGTCATCCTTCTTTCTTC
CTCTACAGAAGTGGTGTCTACTATGAACCATCCTGTACTCAGAATGTGAATCATGGTGTA
CTTGTGGTTGGCTATGGTGATCTTAATGGGAAAGAATACTGGCTTGTGAAAAACAGCTGG
GGCCACAACTTTGGTGAAGAAGGATATATTCGGATGGCAAGAAATAAAGGAAATCATTGT
GGGATTGCTAGCTTTCCCTCTTACCCAGAAATCTAG

# Drug_Target_1_General_Function:
Involved in cysteine-type endopeptidase activity

# Drug_Target_1_General_References:
1373132	Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA: Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem. 1992 Apr 15;267(11):7258-62.
1377692	Wiederanders B, Bromme D, Kirschke H, von Figura K, Schmidt B, Peters C: Phylogenetic conservation of cysteine proteinases. Cloning and expression of a cDNA coding for human cathepsin S. J Biol Chem. 1992 Jul 5;267(19):13708-13.
8157683	Shi GP, Webb AC, Foster KE, Knoll JH, Lemere CA, Munger JS, Chapman HA: Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J Biol Chem. 1994 Apr 15;269(15):11530-6.
9876921	Fengler A, Brandt W: Three-dimensional structures of the cysteine proteases cathepsins K and S deduced by knowledge-based modelling and active site characteristics. Protein Eng. 1998 Nov;11(11):1007-13.

# Drug_Target_1_HGNC_ID:
HGNC:2545

# Drug_Target_1_HPRD_ID:
00292

# Drug_Target_1_ID:
2993

# Drug_Target_1_Locus:
1q21

# Drug_Target_1_Molecular_Weight:
37496

# Drug_Target_1_Name:
Cathepsin S

# Drug_Target_1_Number_of_Residues:
331

# Drug_Target_1_PDB_ID:
1MS6

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00112	Peptidase_C1
PF08246	Inhibitor_I29

# Drug_Target_1_Protein_Sequence:
>Cathepsin S precursor
MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVM
LHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVD
WREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGC
NGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKE
AVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSW
GHNFGEEGYIRMARNKGNHCGIASFPSYPEI

# Drug_Target_1_Reaction:
Similar to cathepsin L, but with much less activity on Z-Phe-Arg!NHMec, and more activity on the Z-Val-Val-Arg! compound

# Drug_Target_1_Signals:
1-16

# Drug_Target_1_Specific_Function:
Thiol protease. Key protease responsible for the removal of the invariant chain from MHC class II molecules. The bond- specificity of this proteinase is in part similar to the specificities of cathepsin L and cathepsin N

# Drug_Target_1_SwissProt_ID:
P25774

# Drug_Target_1_SwissProt_Name:
CATS_HUMAN

# Drug_Target_1_Synonyms:
Cathepsin S precursor
EC 3.4.22.27

# Drug_Target_1_Theoretical_pI:
8.45

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03984
